FDA Warns Antibiotic: Levaquin Linked to Tendon Rupture

Tendon Ruptures, tendonitis Among Most Common Levaquin Injuries

The potent antibiotic Levaquin, used to treat infections throughout the body, has been linked to hundreds of severe tendon ruptures, particularly in the Achilles’ tendon, rotator cuff (shoulder), biceps, hand, and thumb. Significant injuries that require surgery followed by extensive physical therapy is required and injuries that leave patients permanently disabled have been reported nationwide.

Officials do not know the exact reason why Levaquin causes so many tendon ruptures. Tendons may begin to swell, bruise, and ache in the days and weeks before a rupture, but some patients report feeling no pain or other symptoms before their injury.

Most tendon ruptures and cases of tendonitis are sports injuries sustained by men in their 20s and 30s. The connection to the use of Levaquin and similar antibiotics is therefore highly unusual. Levaquin also may result in the following injuries:

  • Swelling of the face and throat
  • Difficulty swallowing
  • Shortness of breath
  • Rapid heartbeat
  • Tingling sensation in the fingers or toes
  • Hives or itching
  • Loss of consciousness

Levaquin Injury Legal Advice is Available

People who have had ruptured tendons, tendonitis, or other injuries after taking the antibiotic Levaquin may be entitled to receive financial compensation for past, present and future medical bills, lost income, and other injuries. At Mark & Associates P.C., we will fight for the best possible legal resolution of your case. Contact us today for a free, no-obligation consultation and evaluation of your possible case by completing the case submission form on this page, or by calling 1-866-50-RIGHTS (1-866-507-4448).

 

You May Have a Defective Drug Case, Find Out Today

Click Here to Call TOLL-FREE
Chat Immediatley - Click Here

Contact us today for an immediate and confidential review of your case.

* denotes a required field

By submitting this form I agree to the following disclaimer.